Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a single-center, open-label pilot study looking at how Guideline-directed management and therapy (GDMP) in post-partum women with preeclampsia can improve Global Longitudinal Strain (GLS).
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:
• Adults between 18 and 45 years of age
• African American
• \>120/80 BP at the time of their 6-month visit in the PARENT study
• Diagnosed with preeclampsia
• Initially presented to University of Chicago Medical Center (UCMC) for a Singleton Gestation Delivery
• Completed the 6 month visit in the PARENT study
Locations
United States
Illinois
University of Chicago Hospital
RECRUITING
Chicago
Contact Information
Primary
Sajid Shahul, MD phd
sshahul1@dacc.uchicago.edu
773-398-2956
Backup
Colleen Duncan, RN
cduncan@bsd.uchicago.edu
773-834-2892
Time Frame
Start Date: 2022-10-27
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 70
Treatments
Active_comparator: Treatment Arm
35 Subjects will be placed in the sub-study treatment arm. These subjects will receive the remote patient monitoring program therapy offered by the University of Chicago heart failure program.
No_intervention: Observational Arm
35 Subjects will be placed in the sub-study Obervational arm. These subjects will not reveive the remote patient monitoring program and will continue with thier standard of care treatment for the duration of the study.
Related Therapeutic Areas
Sponsors
Leads: University of Chicago